{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:08Z","timestamp":1791895448653,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Leading National Research Centre (KNOW), Medical University of Bialystok, Poland","award":["KNOW-0600-SD63-2\/2016"],"award-info":[{"award-number":["KNOW-0600-SD63-2\/2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-04998-4","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:38:13Z","timestamp":1757659093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Standard of practice imaging vs. PET\/MR: a comparative prospective study in rectal cancer staging"],"prefix":"10.1007","volume":"40","author":[{"given":"Rafa\u0142","family":"Maksim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Buczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Sidorkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Mojsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"\u015aliwowska-Burzy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Zuzda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Gugnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kr\u0119towski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"4998_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5\u201329. https:\/\/doi.org\/10.3322\/caac.21254","journal-title":"CA Cancer J Clin"},{"key":"4998_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1148\/rg.2019180114","volume":"39","author":"N Horvat","year":"2019","unstructured":"Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ (2019) MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiogr Rev Publ Radiol Soc N Am Inc 39:367\u2013387. https:\/\/doi.org\/10.1148\/rg.2019180114","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"4998_CR3","first-page":"171","volume":"29","author":"MS Fazeli","year":"2015","unstructured":"Fazeli MS, Keramati MR (2015) Rectal cancer: a review. Med J Islam Repub Iran 29:171","journal-title":"Med J Islam Repub Iran"},{"key":"4998_CR4","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.3748\/wjg.v21.i25.7659","volume":"21","author":"WB Gaertner","year":"2015","unstructured":"Gaertner WB, Kwaan MR, Madoff RD, Melton GB (2015) Rectal cancer: an evidence-based update for primary care providers. World J Gastroenterol 21:7659\u20137671. https:\/\/doi.org\/10.3748\/wjg.v21.i25.7659","journal-title":"World J Gastroenterol"},{"key":"4998_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.20524\/aog.2022.0712","volume":"35","author":"AA Iv","year":"2022","unstructured":"Iv AA, Koprowski MA, Nabavizadeh N, Tsikitis VL (2022) The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation. Ann Gastroenterol 35:226\u2013233. https:\/\/doi.org\/10.20524\/aog.2022.0712","journal-title":"Ann Gastroenterol"},{"key":"4998_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/bjs\/znad177","volume":"110","author":"M Donnelly","year":"2023","unstructured":"Donnelly M, Ryan OK, Ryan \u00c9J, Creavin B, O\u2019Reilly M, McDermott R et al (2023) Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. Br J Surg 110:1316\u20131330. https:\/\/doi.org\/10.1093\/bjs\/znad177","journal-title":"Br J Surg"},{"key":"4998_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142553","volume":"16","author":"R Maksim","year":"2024","unstructured":"Maksim R, Buczy\u0144ska A, Sidorkiewicz I, Kr\u0119towski AJ, Sierko E (2024) Imaging and metabolic diagnostic methods in the stage assessment of rectal cancer. Cancers (Basel) 16:2553. https:\/\/doi.org\/10.3390\/cancers16142553","journal-title":"Cancers (Basel)"},{"key":"4998_CR8","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20160212","volume":"89","author":"P Lovinfosse","year":"2016","unstructured":"Lovinfosse P, Koopmansch B, Lambert F, Jodogne S, Kustermans G, Hatt M et al (2016) 18F-FDG PET\/CT imaging in rectal cancer: relationship with the RAS mutational status. Br J Radiol 89:20160212. https:\/\/doi.org\/10.1259\/bjr.20160212","journal-title":"Br J Radiol"},{"key":"4998_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-019-0237-1","volume":"19","author":"MK Ruteg\u00e5rd","year":"2019","unstructured":"Ruteg\u00e5rd MK, B\u00e5tsman M, Axelsson J, Brynolfsson P, Br\u00e4nnstr\u00f6m F, Ruteg\u00e5rd J et al (2019) PET\/MRI and PET\/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal cancer trial on PET\/MRI\/CT) study. Cancer Imaging 19:52. https:\/\/doi.org\/10.1186\/s40644-019-0237-1","journal-title":"Cancer Imaging"},{"key":"4998_CR10","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) The TNM classification of malignant tumours. 8. Wiley Blackwell, Oxford","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"4998_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","volume":"18","author":"B O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C et al (2017) The TNM classification of malignant tumours\u2014towards common understanding and reasonable expectations. Lancet Oncol 18:849\u2013851. https:\/\/doi.org\/10.1016\/S1470-2045(17)30438-2","journal-title":"Lancet Oncol"},{"key":"4998_CR12","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1097\/SLA.0000000000005755","volume":"278","author":"E Agger","year":"2023","unstructured":"Agger E, J\u00f6rgren F, J\u00f6ud A, Lydrup M-L, Buchwald P (2023) Negative prognostic impact of tumor deposits in rectal cancer: a national study cohort. Ann Surg 278:e526\u2013e533. https:\/\/doi.org\/10.1097\/SLA.0000000000005755","journal-title":"Ann Surg"},{"key":"4998_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04460-z","author":"HZ Lo","year":"2024","unstructured":"Lo HZ, Choy KT, Kong JCH (2024) FDG-PET\/MRI in colorectal cancer care: an updated systematic review. Abdom Radiol N Y. https:\/\/doi.org\/10.1007\/s00261-024-04460-z","journal-title":"Abdom Radiol N Y"},{"key":"4998_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3393\/ac.2018.07.31","volume":"35","author":"S-S Yeom","year":"2019","unstructured":"Yeom S-S, Park IJ, Yang D-H, Lee JL, Yoon YS, Kim CW et al (2019) Variation in the height of rectal cancers according to the diagnostic modalities. Ann Coloproctol 35:24\u201329. https:\/\/doi.org\/10.3393\/ac.2018.07.31","journal-title":"Ann Coloproctol"},{"key":"4998_CR15","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.7150\/jca.52165","volume":"12","author":"D Luo","year":"2021","unstructured":"Luo D, Shan Z, Liu Q, Cai S, Ma Y, Li Q et al (2021) The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy. J Cancer 12:1616\u20131622. https:\/\/doi.org\/10.7150\/jca.52165","journal-title":"J Cancer"},{"key":"4998_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11307-021-01674-1","volume":"24","author":"MA Queiroz","year":"2022","unstructured":"Queiroz MA, Ortega CD, Ferreira FR, Capareli FC, Nahas SC, Cerri GG et al (2022) Value of primary rectal tumor PET\/MRI in the prediction of synchronic metastatic disease. Mol Imaging Biol 24:453\u2013463. https:\/\/doi.org\/10.1007\/s11307-021-01674-1","journal-title":"Mol Imaging Biol"},{"key":"4998_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00259-022-05936-0","volume":"50","author":"A Herold","year":"2022","unstructured":"Herold A, Wassipaul C, Weber M, Lindenlaub F, Rasul S, Stift A et al (2022) Added value of quantitative, multiparametric 18F-FDG PET\/MRI in the locoregional staging of rectal cancer. Eur J Nucl Med Mol Imaging 50:205\u2013217. https:\/\/doi.org\/10.1007\/s00259-022-05936-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4998_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030582","volume":"14","author":"S-W Lee","year":"2022","unstructured":"Lee S-W, Park HL, Yoon N, Kim JH, Oh JK, Buyn JH et al (2022) Prognostic impact of total lesion glycolysis (TLG) from preoperative 18F-FDG PET\/CT in stage II\/III colorectal adenocarcinoma: extending the value of PET\/CT for resectable disease. Cancers 14:582. https:\/\/doi.org\/10.3390\/cancers14030582","journal-title":"Cancers"},{"key":"4998_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.741612","volume":"11","author":"Y-X Yin","year":"2021","unstructured":"Yin Y-X, Xie M-Z, Liang X-Q, Ye M-L, Li J-L, Hu B-L (2021) Clinical significance and prognostic value of the maximum standardized uptake value of 18F-flurodeoxyglucose positron emission tomography-computed tomography in colorectal cancer. Front Oncol 11:741612. https:\/\/doi.org\/10.3389\/fonc.2021.741612","journal-title":"Front Oncol"},{"key":"4998_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5644\/ama2006-124.278","volume":"49","author":"E Sokolovi\u0107","year":"2020","unstructured":"Sokolovi\u0107 E, Ceri\u0107 T, Ceri\u0107 \u0160, Be\u0161lija S, Vegar-Zubovi\u0107 S, Be\u0161li\u0107 N et al (2020) The prognostic value of SUVmax of 18F-FDG PET\/CT in patients with metastatic colorectal cancer. Acta Med Acad 49:1\u20138. https:\/\/doi.org\/10.5644\/ama2006-124.278","journal-title":"Acta Med Acad"},{"key":"4998_CR21","doi-asserted-by":"crossref","unstructured":"Aymard S, Rust E, Kaseb A, Liu D, Hubele F, Romain B, Averous G, Brigand C, Imperiale A (2024) Preoperative 18F-FDG PET\/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up. Cancers 16(1):233","DOI":"10.3390\/cancers16010233"},{"key":"4998_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41416-021-01494-8","volume":"125","author":"FS Furtado","year":"2021","unstructured":"Furtado FS, Suarez-Weiss KE, Vangel M, Clark JW, Cusack JC, Hong T et al (2021) Clinical impact of PET\/MRI in oligometastatic colorectal cancer. Br J Cancer 125:975\u2013982. https:\/\/doi.org\/10.1038\/s41416-021-01494-8","journal-title":"Br J Cancer"},{"key":"4998_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103163","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A et al (2020) 18F-FDG PET\/MR versus MR alone in whole-body primary staging and restaging of patients with rectal cancer: what is the benefit of PET? J Clin Med 9:3163. https:\/\/doi.org\/10.3390\/jcm9103163","journal-title":"J Clin Med"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04998-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04998-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04998-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:38:16Z","timestamp":1757659096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04998-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4998"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04998-4","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and obtained approval from the Medical University in Bialystok, Poland, Institutional Review Board for ethical conduct, No. R-I-002\/218\/2016.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"198"}}